Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Genescà, J
Right arrow Articles by Segura, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Genescà, J
Right arrow Articles by Segura, R
Topic Collections
Right arrowRelevant Article
Gut 2003;52:1054-1059
© 2003 by BMJ Publishing Group & British Society of Gastroenterology


LIVER

Increased tumour necrosis factor {alpha} production in mesenteric lymph nodes of cirrhotic patients with ascites

J Genescà1, R Martí2, F Rojo3, F Campos2, V Peribáñez1, A Gónzalez1, L Castells1, C Ruiz-Marcellán3, C Margarit4, R Esteban1, J Guardia1, R Segura2

1 Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
2 Department of Biochemistry, Hospital Universitari Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
3 Department of Pathology, Hospital Universitari Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
4 Liver Transplantation Unit, Hospital Universitari Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain

Correspondence to:
Correspondence to:
Dr J Genesca, Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d’Hebron, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain;
jgenesca{at}hg.vhebron.es


ABSTRACT
Background: Cytokines produced in mesenteric lymph nodes of cirrhotic rats with bacterial translocation may participate in circulatory alterations of cirrhosis.

Aim: To investigate whether cirrhotic patients present an increased local generation of cytokines in mesenteric lymph nodes.

Methods: Mesenteric lymph nodes from 26 cirrhotic and 10 control patients were assessed for tumour necrosis factor {alpha} (TNF) and interleukin 6 mRNA and protein expression by competitive reverse transcription-polymerase chain reaction, and by enzyme immunoassay and immunohistochemistry, respectively.

Results: Interleukin 6 levels were not different between cirrhotics and controls. Protein and mRNA TNF levels in mesenteric lymph nodes from cirrhotics were higher than in controls (p<0.05). Tissue expression of TNF by immunohistochemistry was more abundant in cirrhotics. Ascitic patients showed higher TNF levels (47 (34–54) pg/mg protein) than patients without ascites (18 (17–25) pg/mg protein) (p<0.001). Elevated TNF levels (>28 pg/mg protein) in cirrhotics were associated with a higher Child-Pugh score, the antecedent of ascites, a lower prothrombin rate, and higher bilirubin and blood TNF levels. The strongest association, confirmed by multivariate analysis, was with the presence of ascites (p<0.001). Bacterial infections after transplantation, mainly by enteric bacteria, were only detected in patients with high TNF levels in mesenteric lymph nodes (33% of patients; p=0.05).

Conclusion: Patients with advanced liver cirrhosis, and especially with ascites, have increased local production of TNF in mesenteric lymph nodes that, in common with experimental cirrhosis, may also be induced by bacterial translocation.


Keywords: cytokines; bacterial translocation; splanchnic vasodilation; nitric oxide; portal hypertension

Abbreviations: NO, nitric oxide; TNF, tumour necrosis factor {alpha}; iNOS, inducible nitric oxide synthase; eNOS, endothelial nitric oxide synthase; MLN, mesenteric lymph nodes; IL-6, interleukin 6; PCR, polymerase chain reaction; ICS, internal calibration standard; EIA, enzyme immunoassays; GAPDH, glyceraldehyde-3-phosphate dehydrogenase


Relevant Article

Digest
Robin Spiller
Gut 2003 52: 917. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Med MicrobiolHome page
M. M. El-Naggar, E.-S. A.-M. Khalil, M. A. M. El-Daker, and M. F. Salama
Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites
J. Med. Microbiol., December 1, 2008; 57(12): 1533 - 1538.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
U Thalheimer and A K Burroughs
Bacterial translocation and cardiovascular complications of cirrhosis
Gut, August 1, 2008; 57(8): 1181 - 1181.
[Full Text] [PDF]


Home page
GutHome page
V Lorenzo-Zuniga, C M Rodriguez-Ortigosa, R Bartoli, M-L Martinez-Chantar, L Martinez-Peralta, A Pardo, I Ojanguren, J Quiroga, R Planas, and J Prieto
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats
Gut, September 1, 2006; 55(9): 1306 - 1312.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
U Thalheimer, C K Triantos, D N Samonakis, D Patch, and A K Burroughs
Infection, coagulation, and variceal bleeding in cirrhosis
Gut, April 1, 2005; 54(4): 556 - 563.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology